Dry eyes and mouth: is it always Sjögren’s?
Persistent dryness deserves attention, but it has several possible causes and no single test settles every case.
In Depth · Patients & Caregivers · EN
Olga Goodman, MD · Rheumatology in Perspective
Published · Updated September 26, 2026
In this article
Dryness is a symptom; Sjögren’s is a systemic disease
Dry eyes and a dry mouth often occur together, but that combination does not automatically mean Sjögren’s disease. “Sicca” simply describes dryness. Sjögren’s is an autoimmune disease in which the immune system can affect tear and salivary glands and, in some people, other organs. The useful assessment asks two questions: what is causing the dryness, and is there evidence of a wider disease?
This expanded patient edition follows the original RheumaView discussion from symptoms to gland biology and treatment. The original film focused on mechanisms under investigation. Understanding those mechanisms is useful, but a promising research result is not the same as a treatment approved and appropriate for an individual patient.
Watch: Sjögren’s from dryness to immune mechanisms
The original RheumaView film shows how inflammation affects the glands and why researchers target communication between immune cells. Follow the images first; the terms below provide a guide.
Open video separately · Original article
What to look for. BAFF supports B-cell survival; BAFF-R is its receptor. CD40–CD40L is one route of communication between T and B cells. These labels identify mechanisms, not tests every patient needs.
This professional overview includes treatments that were investigational when recorded. Symptom relief and treatment of systemic manifestations are distinct; the article explains both. Trial and approval status can change.
Why eyes or mouth can feel dry
Tears are more than water. The tear film also needs an adequate oily layer and a healthy eye surface. Problems with the eyelid oil glands can make tears evaporate too quickly even when tear production is not profoundly reduced. Contact lenses, eyelid inflammation, screen-related reductions in blinking, airflow and other eye conditions may contribute.
Saliva lubricates food, assists swallowing and protects teeth and oral tissues. A dry mouth can result from reduced production, mouth breathing, dehydration or medication effects. Antihistamines and some antidepressant, bladder and other medicines are common contributors. Several factors can operate at once. Do not stop prescribed medicines yourself: a medication review should weigh both the benefit and the adverse effect.
| Possible contributor | Useful clues | What helps clarify it |
|---|---|---|
| Medication effect | Onset after a new medicine or dose change; several drying medicines | Review prescriptions, over-the-counter products and timing |
| Eye-surface or eyelid problem | Burning, fluctuating blur, irritation, contact-lens symptoms | Eye examination rather than a blood test alone |
| Mouth breathing or dehydration | Morning dryness, nasal symptoms, fluid losses | History and assessment of the underlying cause |
| Sjögren’s or another systemic condition | Persistent dryness with compatible gland, joint, skin or other findings | Combined clinical, gland-function and directed laboratory evaluation |
Diabetes, previous head-and-neck treatment and other medical conditions may need consideration. A dry sensation and an objectively low tear or saliva output are related but not identical findings.
What happens to the glands in Sjögren’s?
Lymphocytes can infiltrate gland tissue and interfere with its function. B cells, which produce antibodies, and T cells participate in an abnormal immune response. BAFF is a survival signal for B cells; excessive or poorly regulated survival can allow autoreactive cells to persist. Type-I interferon signaling and the communication between T and B cells also participate.
The original article describes CD40–CD40L as one communication pathway and BAFF-receptor targeting as another research strategy. These pathways explain why investigators are testing treatments that modify immune activity rather than simply add moisture. They do not mean every patient has the same mechanism, that every damaged gland can recover, or that stronger immunosuppression is the answer to all dryness.
Which features make a fuller assessment worthwhile?
Daily persistent dryness, repeatedly needing water to swallow dry food, recurrent cavities, oral thrush or swelling near the jaw or ears deserve discussion. Ask about significant fatigue, inflammatory joint symptoms, rashes, numbness or neuropathic pain, persistent cough and breathlessness. Sjögren’s can have systemic manifestations, but common symptoms such as fatigue also have many other causes.
Describe when dryness started, whether it is constant, what makes it worse and which treatments help. Dental history and eye-examination reports are valuable. The rheumatologist, eye clinician and dentist contribute different evidence; none should be expected to answer every part alone.
Diagnosis uses several kinds of evidence
Eye testing may assess the ocular surface, tear-film stability, tear production and staining that shows surface damage. Salivary assessment can measure saliva output and examine the glands. Blood tests, including anti-SSA/Ro when appropriate, help evaluate autoimmunity. A negative SSA test does not exclude Sjögren’s, and a positive antibody alone does not establish it.
In selected cases, a minor salivary-gland biopsy from the inner lip can provide additional evidence. The decision depends on the question it is expected to resolve, other findings and the procedure's risks, including local discomfort and possible sensory changes. It is not an automatic test for every dry mouth. Salivary-gland ultrasound can be helpful in experienced hands but must also be interpreted in context.
Classification criteria help create comparable research groups. They are not a home calculator or a substitute for clinical diagnosis. An individual assessment also considers conditions that mimic Sjögren’s. Not everyone needs every test, and repeating antibody panels does not substitute for examining the affected tissues.
Protect the eyes and teeth while the cause is investigated
Eye care may include lubricants, sometimes preservative-free when frequent use is needed, and treatment of eyelid or ocular-surface inflammation. Prescription anti-inflammatory drops or other procedures may be appropriate after examination. Avoid prolonged self-treatment with “redness relief” drops; redness can have several causes.
For the mouth, discuss fluoride toothpaste, preventive dental care, saliva substitutes and sugar-free gum or lozenges when safe for swallowing. Frequent sugary or acidic sweets can worsen dental problems even if they temporarily stimulate saliva. Small sips of water may improve comfort, but respect heart or kidney fluid restrictions. Medicines that stimulate saliva can help selected patients; contraindications and side effects need review.
Moisture replacement, infection treatment and dental prevention have different jobs. Thrush may need antifungal treatment. Water alone does not replace all the protective functions of saliva, and relief of dryness does not tell us whether systemic inflammation is controlled.
Systemic treatment is chosen for the manifestation
Significant inflammatory joint, skin, nerve, lung or kidney involvement may require treatment beyond lubricants. Clinicians sometimes use hydroxychloroquine or other immunomodulating medicines for selected manifestations. Benefit for one manifestation should not be assumed to prove benefit for every symptom. Dryness, fatigue and active organ inflammation need separate assessment.
Clinical trials are investigating pathways including BAFF/BAFF-R and CD40/CD40L. Ianalumab combines BAFF-receptor blockade with B-cell depletion; it is discussed in the original research material as a developing therapeutic approach. A development designation such as “breakthrough therapy” is not marketing approval. Before making a treatment decision, verify current regulatory status, availability and the evidence relevant to your situation with your clinician. Trial participation has its own eligibility, consent and monitoring requirements.
Lymphoma risk: important without turning every symptom into an alarm
Sjögren’s increases the risk of lymphoma, but most people with Sjögren’s do not develop it. Persistent or asymmetric salivary-gland enlargement, enlarging lymph nodes, unexplained weight loss, persistent fever or drenching night sweats should be assessed. These symptoms also have other causes. An individual risk estimate depends on the clinical pattern and laboratory findings; a single percentage from the internet does not describe every patient.
A practical follow-up plan
Ask who is monitoring eye-surface health, dental damage and systemic features; how often review is needed; and which changes should trigger an earlier appointment. Bring a concise record of dryness, fatigue, gland swelling, new symptoms and treatment effects. A symptom diary can describe burden, but it cannot diagnose gland inflammation or replace organ-specific testing.
Urgent eye assessment is needed for eye pain, significant redness, light sensitivity or reduced vision. New severe breathlessness, neurological weakness or rapid deterioration needs urgent medical evaluation. Persistent new gland swelling warrants timely assessment rather than being assumed to be ordinary dryness.
Sources and further reading
Expanded patient edition based on the original publications, with additional explanations and clinical context. The source articles retain their original professional or narrative format.
Original RheumaView articles by Olga Goodman, MD
- Sjögren's Syndrome: from dryness to disease modification
- A Case of Sicca. Sjögren's and Its Mimics: A Case You Run
Clinical references
- NIAMS — Sjögren’s disease: diagnosis and treatment
- Novartis — ianalumab regulatory announcement, 16 January 2026
© Olga Goodman, MD · Reuse requires attribution and a link to the original publication.